Onkologie. 2019:13(2):63-68 | DOI: 10.36290/xon.2019.012

Gastrointestinal tumors in children

Viera Bajčiová
Klinika dětské onkologie LF MU a FN Brno

Gastrointestinal tumors in children and adolescents are very rare. They differ from the adult gastrointestinal cancer in different
histological types of tumors, their incidence, etiology and clinical symptoms. Experience with their diagnosis and treatment in
children are limited. The fundamental difference from the adult gastrointestinal cancer is absence of pediatric clinical trials. An
exception is the treatment of pediatric abdominal non-Hodgkin lymphoma. Cooperation and experience of adults oncology are
therefore necessary.

Keywords: gastrointestinal tumors, pediatric tumors, differences, clinical studies

Published: April 5, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bajčiová V. Gastrointestinal tumors in children. Onkologie. 2019;13(2):63-68. doi: 10.36290/xon.2019.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ladd AP, Grosfeld JL. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg 2006; 15(1): 37-47. Go to original source... Go to PubMed...
    2. Zhuge Y, Cheung MC, Yeang R, et al. Pediatric intestinal foregut and small bowel solid tumors: a review of 105 cases. J Surg Res 2009; 156(1): 95-102. Go to original source... Go to PubMed...
    3. Dousek R, Tuma J, Planka L, et al. Inflammatory myofibroblastic tumor of the esophagus in childhood: a case report and a review of the literature. J Pediatr Hematol Oncol 2015; 37(2): 121-124. Go to original source... Go to PubMed...
    4. Tay CH H, Lee H CH, Yeung CH Y, et al. Different clinical manifestations between primary gastrointestinal malignancies and benign tumors in children. JPGN 2012; 55: 440-444. Go to original source... Go to PubMed...
    5. Bethel CA, Bhattacharyya N, Hutchinson C, et al. Alimentary tract malignancies in children. J Pediatr Surg 1997; 32(7): 1004-1008. Go to original source... Go to PubMed...
    6. Yang R, Cheueng MC, Zhuge Y, et al. Primary solid tumors of the colon and rectum in the pediatric patient: a review of 270 cases. J Surg Res 2010; 161(2): 209-216. Go to original source... Go to PubMed...
    7. Sultan I, Rodriques-Galindo C, El-Taani H, et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer 2010; 116(3): 758-765. Go to original source... Go to PubMed...
    8. Poles GC, Clark DE, Mayo SW, et al. Colorectal carcinoma in pediatric patients: a comparison with adult tumors, treatment and outcomes from the National Cancer database. J Pediatr Surg 2016; 51(7): 1061-1066. Go to original source... Go to PubMed...
    9. Weber ML, Schneider DT, Offenmuller S, et al. Pediatric colorectal carcinoma is associated with excellent outcome in the context of cancer predisposition syndromes. Pediatr Blood Cancer 2016; 63: 611-617. Go to original source... Go to PubMed...
    10. Hill DA, Furman WL, Billupsa CA, et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. JCO 2007; 25(36): 5808-5814. Go to original source... Go to PubMed...
    11. Wayne I, et al. Colorectal cancer, Chapter 20 in Bleyer AW, Barr RD: Cancer in adolescents and young adults, Springer-Verlag Berlin 2007.
    12. Tomášek J, Němec J. Karcinom tlustého střeva a konečníku, kapitola 12, str 153 - 160 in Bajčiová V, Tomášek J, Štěrba J: Nádory u adolescentů, Grada 2011.
    13. Ferrari A. Intestinal carcinomas. Chapter 32 in Schneider DT, Brecht IM, Olson TA: Rare tumors in children and adolescents, pp.269-276, Springer - Verlag Berlin 2012. Go to original source...
    14. Bajčiová V. Neuroendokrinní nádory u dětí a dospívajících, kapitola 19 v monografii Sedláčková E, Bajčiová V: Neuroendokrinní nádory Maxdorf-Jessenius 2016: 331-341.
    15. Redlich A, Boxberger N, Vorwerk P. Neuroendocrine tumor sof the apendix. Chapter 33 in Schneider DT, Brecht IM, Olson TA. Rare tumors in children and adolescents, pp.277 - 278, Springer - Verlag Berlin 2012. Go to original source...
    16. Benesch M. Gastrointestinal stromal tumors, Chapter 34 in Schneider DT, Brecht IM, Olson TA: Rare tumors in children and adolescents, pp.279-282, Springer - Verlag Berlin 2012. Go to original source...
    17. Goldberg JFW. Management of colorectal carcinoma in children and young adults. J Pediatr Hematol Oncol 2012; 34: 76-79. Go to original source... Go to PubMed...
    18. Cohen S, Gorodnichenco A, Weiss B, et al. Polyposis syndromes in children and adolescents: a case series data analysis. Eur J Gastroenterol Hepatol 2014; 26(9): 972-927. Go to original source... Go to PubMed...
    19. Salas-Valverde S, Lizano A, Gamboa Y, et al. Colon Carcinoma in children and adolesents: Prognostic factors and outcome - a review of 11 cases. Pediatr Surg Int 2009; 25(12): 1073-1076. Go to original source... Go to PubMed...
    20. Durno C, Aronson M, Bapat B, et al. Family history and molecular features of children, adolesdents and young adults with colorectal carcinoma. Gut 2005; 54: 1146-1150. Go to original source... Go to PubMed...
    21. Mottl H. Problematika kolorektálního karcinomu u dětí a dospívajících. Lékařské listy 2013; 4: 39-40.
    22. Bertario L, Signoroni S. Gastrointestinal cancer predisposition syndromes. Chapter 30 in Schneider DT, Brecht IM, Olson TA: Rare tumors in children and adolescents, pp.255 - 262, Springer - Verlag Berlin 2012. Go to original source...
    23. Poš L, Rousková B, Kynčl M, et al. Kolorektální karcinom v dětském věku. Onkologie 2015; 9(5): 242-244.
    24. Bajčiová V. Genetické predispoziční syndromy v dětském věku - zkušenosti KDO Klinická onkologie, 2016; 29(Suppl 1): 62-70. Go to original source... Go to PubMed...
    25. Kappelmann MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol hepatol 2014; 12(2): 265-273. Go to original source... Go to PubMed...
    26. Campos FG, Teixeira MG, Scanavini A, et al. Intestinal and extraintestinal neoplasia in patients with inflammatory bowel disease in a tertiary care hospital. Arq Gastroenterol 2013; 50(2): 123-129. Go to original source... Go to PubMed...
    27. Rufo P. Inflammatory bowel disease and neoplasia in children. Dig Dis 2014; 32(4): 455-462. Go to original source... Go to PubMed...
    28. Virgone C, Cecchito G, Alaggio R, et al. Appendiceal neuroendocrine tumours in childhood: Italian TREP project. J Pediatr Gastroenterol N utr 2014; 58(3): 333-338. Go to original source... Go to PubMed...
    29. Kupeli S, Varan A, Dermir H, et al. Association of Helicobacter pylori and childhood lymphoma. J Pediatr Hematol Oncol 2007; 29(5): 301-304. Go to original source... Go to PubMed...
    30. Fox VL. Gastrointestinal bleeding in infancy and childhood. Gastroenterol Clin North Am 2000; 29(1): 37-66. Go to original source... Go to PubMed...
    31. Edelman DA, Sugawa CH. Lower gastrointestinal bleeding: a review. Surg Endosc 2007; 21: 514-520. Go to original source... Go to PubMed...
    32. Bhatia V, Lodha R. Upper gastrointestinal bleeding. Indian J Pediatr 2011;78: 227-233. Go to original source... Go to PubMed...
    33. Koh K-J, Lin L-H, Huang S-H, et al. CARE - Pediatric colon adenocarcinoma. Medicine 2015; 94(6): 5093. Go to original source... Go to PubMed...
    34. Sridharan M, Hubbard JM, Grothey A. Colorectal cancer: how emerging molecular understanding affects treatment decisions. Oncology 2014; 28(2): 110-118. Go to PubMed...
    35. Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-386. Go to original source... Go to PubMed...
    36. Kassira N, Pedroso FE, Cheung MC, et al. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the SEER registry. J Pediatr Surg 2011; 46(10): 1956-1964. Go to original source... Go to PubMed...
    37. Maus MKH, Hanna DL, Stephens CL, et al. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenom Journal 2015; 15: 354-362. Go to original source... Go to PubMed...
    38. Westdorp H, Kolders S, Hoogerbrugge N, et al. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CDMMR) syndrome. Cancer Lett 2016; 403: 159-164. Go to original source... Go to PubMed...
    39. Bajčiová V. Role imunoterapie v dětské onkologii. Klinická onkologie 2015; 28(Suppl 4): 38-43. Go to original source... Go to PubMed...
    40. Beuer KM, Le DT. An expanding role for immunotherapy in colorectal cancer. J Natl Compr Cancer Netw 2017; 15(3): 401-410. Go to original source... Go to PubMed...
    41. Yaghoubi N, Sotani A, Ghazvini K, et al. PD-1/PD-L1 blockade as a novel treatment for colorectal cancer. Biomed Pharmacother 2019; 110: 312-318. Go to original source... Go to PubMed...
    42. Daniel CL, Kohler CL, Stratton KL, et al. Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. Cancer 2015; 121(11): 1856-1863. Go to original source... Go to PubMed...
    43. Jensen BW, Gamborg M, Gogenur I, et al. Childhood body mass index and height in relation to side-specific risks of colorectal cancer in adult life. J Epidemiol 2017; 32: 1097-1106. Go to original source...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.